Skip to content
Bamboo WorksBamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

National Reimbursement Drug List

Illustration of McDonald's Big Mac

A McDonald’s Valuation Downsize, and New Medical Plan Additions

The value of McDonald's China operation has plunged by more than half in the last year.  And 91 companies got their drugs added to China's national health plan By Doug…
December 3, 2024
Sihuan Pharmaceutical announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of China’s National Reimbursement Drug List under the nation’s health plan.

FAST NEWS: Four Sihuan affiliate products included in China’s national health plan

The latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of…
January 10, 2024
0460.HK
Hutchmed (China) Ltd. announced Monday a net profit of $169 million in the first half of 2023, reversing a loss of $163 million in the same period last year.

FAST NEWS: Hutchmed swings to profit on strong revenue growth

The latest: Hutchmed (China) Ltd. (HCM.US; 0013.HK) announced Monday a net profit of $169 million in the first half of 2023, reversing a loss of $163 million in the same period…
August 1, 2023
HCM.US 0013.HK

FAST NEWS: Hutchmed, Zai Lab, Ascentage Drugs Land on China Reimbursement List

The latest: Products from Hutchmed (China) Ltd. (HCM.US; 0013.HK), Zai Lab Ltd. (ZLAB.US; 9688.HK) and Ascentage Pharma Group (6855.HK) were among 111 new drugs selected for new inclusion in the…
January 19, 2023

FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit

The latest: InnoCare Pharma Ltd. (9969.HK) issued a profit warning Friday, estimating a net loss of no more than 495 million yuan ($73 million) for the first half of this year,…
August 5, 2022

FAST NEWS: InnoCare Pharma Granted Production Approval for Guangzhou Facility

The latest: InnoCare Pharma Ltd. (9969.HK) announced Monday its Guangzhou manufacturing facility has been approved by the China National Medical Products Administration (NMPA) to start the production of commercial supply of its…
July 5, 2022

FAST NEWS: Kintor Pharma Soars on Good Results for Covid Drug

The latest: Kintor Pharmaceutical Ltd. (9939.HK) on Wednesday announced positive results from a Phase 3 clinical trial for its drug Proxalutamide for the treatment of mild-to-moderate ambulatory Covid-19 patients, saying…
April 6, 2022
Load more

Recent Articles

Illustration of McDonald's Big Mac
December 3, 2024

A McDonald’s Valuation Downsize, and New Medical Plan Additions

January 10, 2024

FAST NEWS: Four Sihuan affiliate products included in China’s national health plan

0460.HK
August 1, 2023

FAST NEWS: Hutchmed swings to profit on strong revenue growth

HCM.US 0013.HK
January 19, 2023

FAST NEWS: Hutchmed, Zai Lab, Ascentage Drugs Land on China Reimbursement List

August 5, 2022

FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit

July 5, 2022

FAST NEWS: InnoCare Pharma Granted Production Approval for Guangzhou Facility

April 6, 2022

FAST NEWS: Kintor Pharma Soars on Good Results for Covid Drug

RECENT ARTICLES

  1. Everest's nefecon included on national drug list
    December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  2. February 4, 2025
    Chicken challenger Ting-Qiao preps for Hong Kong IPO
  3. January 7, 2025
    Weak sentiment may leave Auntea Jenny thirsty for better valuation
  4. March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  5. November 26, 2024
    Starbucks looks for new friends in choppy China coffee waters
    SBUX.US
  6. February 4, 2025
    Fortior hopes to ride China chip wave to high valuation
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.